| Literature DB >> 34287352 |
Aikaterini Moschou1, Petros Ioannou1, Eleni Moraitaki2, Dimitra Stafylaki2, Sofia Maraki2, George Samonis1, Diamantis P Kofteridis1.
Abstract
(1) Background: In an area with a high prevalence of multi-drug resistant Gram-negative bacteria (MDR-GNB), we investigated the colonization of nursing home residents by such organisms. (2)Entities:
Keywords: ESBL; MDR; long-term care; multi-drug resistance; nursing homes
Year: 2021 PMID: 34287352 PMCID: PMC8293340 DOI: 10.3390/tropicalmed6030123
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
Isolated microorganisms.
| Isolate | # of Isolates | % Among All Isolates |
|---|---|---|
| 164 | 64.3 | |
| 30 | 11.8 | |
| 14 | 5.5 | |
| 13 | 5.1 | |
|
| 8 | 3.1 |
|
| 5 | 2 |
|
| 3 | 1.2 |
|
| 2 | 0.8 |
|
| 2 | 0.8 |
|
| 2 | 0.8 |
|
| 2 | 0.8 |
| 2 | 0.8 | |
|
| 1 | 0.4 |
|
| 1 | 0.4 |
|
| 1 | 0.4 |
|
| 1 | 0.4 |
|
| 1 | 0.4 |
|
| 1 | 0.4 |
|
| 1 | 0.4 |
|
| 1 | 0.4 |
#: number; %: percentage; ESBL: extended-spectrum beta lactamase; MDR: multi-drug resistant.
Characteristics of LTCF residents regarding hospitalization within the last 3 months.
| Hospitalization within 3 m (n = 7) | No Hospitalization within 3 m (n = 130) |
| |
|---|---|---|---|
| Male gender, n (%) | 1 (14.3) | 26 (20) | 1 |
| Age, mean (SD) | 84.7 (5.3) | 82.1 (8.4) | 0.4082 |
| Length of LTCF stay, months, median (IQR) | 12 (2–70) | 22 (10–48) | 0.5537 |
| Charlson > or = to 3, n (%) | 1 (14.3) | 15 (11.5) | 0.5895 |
| Diabetes, n (%) | 1 (14.3) | 26 (20) | 1 |
| Neurologic disorder, n (%) | 5 (71.4) | 103 (79.2) | 0.6391 |
| Urinary catheter, n (%) | 1 (14.3) | 6 (4.6) | 0.3132 |
| Antimicrobial use within 3 m, n (%) | 6 (85.7) | 6 (4.6) | <0.0001 |
| ESBL carriers, n (%) | 4 (57.1) | 32 (24.6) | 0.0775 |
| MDR-GNB carriers, n (%) | 3 (42.9) | 30 (23.1) | 0.3587 |
n: number; %: percentage; SD: standard deviation; LTCF: long-term care facility; IQR: interquartile range; ESBL: extended-spectrum beta lactamase; MDR-GNB: multi-drug resistant Gram-negative bacteria; p: p-value.
Characteristics of LTCF residents regarding antimicrobial use within the last 3 months.
| Antimicrobial Use within 3 m (n = 12) | No Antimicrobial Use within 3 m (n = 125) |
| |
|---|---|---|---|
| Male gender, n (%) | 1 (8.3) | 26 (20.8) | 0.4595 |
| Age, mean (SD) | 83.3 (6.2) | 81.9 (8.6) | 0.5813 |
| Length of LTCF stay, months, median (IQR) | 13.5 (7–30.75) | 23 (10–48) | 0.2180 |
| Charlson > or = to 3, n (%) | 1 (8.3) | 15 (12) | 1 |
| Diabetes, n (%) | 3 (25) | 24 (19.2) | 0.7039 |
| Neurologic disorder, n (%) | 10 (83.3) | 98 (78.4) | 1 |
| Urinary catheter, n (%) | 1 (8.3) | 6 (4.8) | 0.4815 |
| Hospitalization within 3 m, n (%) | 6 (50) | 1 (0.8) | <0.0001 |
| ESBL carriers, n (%) | 7 (58.3) | 29 (23.2) | 0.0144 |
| MDR-GNB carriers, n (%) | 6 (50) | 27 (21.6) | 0.0386 |
n: number; %: percentage; SD: standard deviation; LTCF: long-term care facility; IQR: interquartile range; ESBL: extended-spectrum beta lactamase; MDR-GNB: multi-drug resistant Gram-negative bacteria; p: p-value.
Characteristics of LTCF residents regarding colonization by MDR-GNB.
| MDR-GNB Carriers (n = 33) | No MDR-GNB Carriers (n = 104) |
| |
|---|---|---|---|
| Male gender, n (%) | 10 (30.3) | 17 (16.3) | 0.1294 |
| Age, mean (SD) | 83.2 (5.9) | 81.7 (9) | 0.3511 |
| Length of LTCF stay, months, median (IQR) | 13 (8.5–29.5) | 24 (10–48) | 0.0771 |
| Charlson > or = to 3, n (%) | 3 (9.1) | 13 (12.5) | 0.7610 |
| Diabetes, n (%) | 4 (12.1) | 23 (22.1) | 0.3147 |
| Neurologic disorder, n (%) | 27 (81.8) | 81 (77.9) | 0.8076 |
| Urinary catheter, n (%) | 7 (21.2) | 0 (0) | <0.0001 |
| Hospitalization within 3 m, n (%) | 3 (9.1) | 4 (3.8) | 0.3587 |
| Antimicrobial use within 3 m, n (%) | 6 (18.2) | 6 (5.8) | 0.0386 |
| ESBL carriers, n (%) | 33 (100) | 3 (2.9) | <0.0001 |
n: number; %: percentage; SD: standard deviation; LTCF: long-term care facility; IQR: interquartile range; ESBL: extended-spectrum beta lactamase; MDR-GNB: multi-drug resistant Gram-negative bacteria; p: p-value.
Characteristics of LTCF residents regarding colonization by ESBL-producing microorganisms.
| ESBL Carriers (n = 36) | No ESBL Carriers (n = 101) |
| |
|---|---|---|---|
| Male gender, n (%) | 11 (30.6) | 16 (15.8) | 0.0855 |
| Age, mean (SD) | 83.7 (6.6) | 81.5 (8.8) | 0.197 |
| Length of LTCF stay, months, median (IQR) | 13 (8.5–29.5) | 24 (10–48) | 0.0834 |
| Charlson > or = to 3, n (%) | 3 (8.3) | 13 (12.9) | 0.5603 |
| Diabetes, n (%) | 4 (11.1) | 23 (22.7) | 0.1509 |
| Neurologic disorder, n (%) | 30 (83.3) | 78 (77.2) | 0.4879 |
| Urinary catheter, n (%) | 7 (19.4) | 0 (0) | <0.0001 |
| Hospitalization within 3 m, n (%) | 4 (11.1) | 3 (3) | 0.0775 |
| Antimicrobial use within 3 m, n (%) | 7 (19.4) | 5 (5) | 0.0144 |
| MDR-GNB carriers, n (%) | 33 (91.7) | 0 (0) | <0.0001 |
n: number; %: percentage; SD: standard deviation; LTCF: long-term care facility; IQR: interquartile range; ESBL: extended-spectrum beta lactamase; MDR-GNB: multi-drug resistant Gram-negative bacteria; p: p-value.
Regression analysis of colonization of LTCF residents by ESBL-producing microorganisms or MDR-GNB.
| ESBL | Univariate Analysis | Multivariate Analysis | OR (95% CI) |
|---|---|---|---|
| Male gender | 0.0573 | 0.005 | 4.358 (1.543–12.313) |
| Length of stay in LTCF | 0.0775 | 0.066 | 0.985 (0.97–1.001) |
| Urinary catheter | <0.0001 | 0.999 | 6.356 × 109 (0.000–infinity) |
| Hospitalization within 3 months | 0.0574 | 0.975 | 0.962 (0.088–10.537) |
| Antimicrobial use within 3 months | 0.008 | 0.049 | 5.429 (1.006–29.288) |
|
|
|
|
|
| Male gender | 0.0801 | 0.009 | 4.067 (1.415–11.694) |
| Length of stay in LTCF | 0.0771 | 0.063 | 0.984 (0.968–1.001) |
| Urinary catheter | <0.0001 | 0.999 | 7.297 × 109 (0.000–infinity) |
| Antimicrobial use within 3 months | 0.028 | 0.044 | 3.985 (1.037–15.323) |
CI: confidence interval; LTCF: long-term care facility; ESBL: extended-spectrum beta lactamase; MDR-GNB: multi-drug resistant Gram-negative bacteria; OR: odds ratio; p: p-value.